Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review

Published:2020-01-01 Issue:1 Volume:38 Page:112-116
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Yehya Ahmad¹,Sadhu Archana¹

Affiliation:

1. Division of Endocrinology, Diabetes & Metabolism, Houston Methodist Hospital, Houston, TX

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/38/1/112/501389/112.pdf

Reference30 articles.

1. Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications;Bakris;Kidney Int,2009

2. Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus;Abdul-Ghani;Endocr Pract,2008

3. Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus;Nair;J Clin Endocrinol Metab,2010

4. Update on developments with SGLT2 inhibitors in the management of type 2 diabetes;Nauck;Drug Des Devel Ther,2014

5. Effect of sodium-glucose cotransport-2 inhibitors on blood pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43 randomized control trials with 22,528 patients;Mazidi;J Am Heart Assoc,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Postmarketing Cases;Endocrine Practice;2024-07

2. Empagliflozin;Reactions Weekly;2022-11-12

3. Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis;Journal of International Medical Research;2022-03

4. Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy;Clinical Case Reports;2021-11

5. SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort;Scientific Reports;2021-05-13